Development

A decades-old target falls as hepatitis B is functionally cured in 19%

development2026-06-08

Claim

GSK's bepirovirsen functionally cured 19% of hepatitis B patients, clearing a hurdle chased for decades and relevant to 300 million people.

Reported metric: 19% functional cure

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Knowledge graphopen in browser →

Reported in
Actor
Evidence for
Supersedes
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.